North America Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024

List of Tables

The North America Human Insulin Market would witness market growth of 2.7% CAGR during the forecast period (2024-2031).

The US market dominated the North America Human Insulin Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $5,044.3 million by 2031. The Canada market is experiencing a CAGR of 4.9% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 4% during (2024 - 2031).

Diabetes is a chronic disorder that affects millions of individuals. Since the discovery of insulin, the market for insulin has undergone substantial development, and it now plays an essential part in the management of diabetes. The need for effective diabetes treatments has increased in tandem with the increasing prevalence of diabetes, which is influenced by factors such as elderly populations, unhealthy diets, and sedentary lifestyles. Particularly for patients with type 1 diabetes and those with advanced type 2 diabetes, insulin, a hormone that is indispensable for managing blood glucose levels, continues to be a fundamental component of diabetes treatment.

The growing number of people who are diagnosed with diabetes is one of the key factors that is driving market expansion. This concerning trend emphasizes the pressing necessity for insulin-based diabetes management solutions. The prevalence of diabetes is not exclusively prevalent in high-income countries; it is also increasing at a rapid pace in low- and middle-income countries, where healthcare systems frequently encounter difficulties in managing the burden of chronic diseases.

Public health initiatives focused on diabetes prevention and management further support market growth in North America. Programs like the National Diabetes Prevention Program (NDPP) in the United States aim to reduce the incidence of type 2 diabetes through lifestyle interventions and education. In Canada, the Diabetes 360° initiative advocates for a national diabetes strategy to improve prevention, care, and outcomes for diabetic patients. These initiatives raise awareness about diabetes, promote early detection, and encourage adherence to treatment regimens, increasing the demand for insulin. Therefore, the region presents lucrative growth opportunities for the market in the coming years.

Based on Indication, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, and Gestational Diabetes. Based on Product Type, the market is segmented into Pens, Syringes, and Others. Based on Type of Insulin, the market is segmented into Rapid-acting insulin, Short-acting insulin, Intermediate-acting insulin, and Others. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Drug Stores & Retail Pharmacies, and Online Providers. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

MannKind Corporation
Lupin Limited
Sanofi S.A.
Novo Nordisk A/S
Eli Lilly And Company
Medtronic PLC
Biocon Limited
Tonghua Dongbao Pharmaceutical Co., Ltd.
Pfizer, Inc.

North America Human Insulin Market Report Segmentation

By Indication

Type 1 Diabetes
Type 2 Diabetes
Gestational Diabetes

By Product Type

Pens
Syringes
Others

By Type of Insulin

Rapid-acting insulin
Short-acting insulin
Intermediate-acting insulin
Others

By Distribution Channel

Hospital Pharmacies
Drug Stores & Retail Pharmacies
Online Providers

By Country

US
Canada
Mexico
Rest of North America

Chapter 1. Market Scope & Methodology

1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
- 1.4.1 North America Human Insulin Market, by Indication
- 1.4.2 North America Human Insulin Market, by Product Type
- 1.4.3 North America Human Insulin Market, by Type of Insulin
- 1.4.4 North America Human Insulin Market, by Distribution Channel
- 1.4.5 North America Human Insulin Market, by Country
1.5 Methodology for the research

Chapter 2. Market at a Glance

2.1 Key Highlights

Chapter 3. Market Overview

3.1 Introduction
- 3.1.1 Overview
  - 3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
3.3 Porter Five Forces Analysis

Chapter 4. North America Human Insulin Market by Indication

4.1 North America Type 1 Diabetes Market by Country
4.2 North America Type 2 Diabetes Market by Country
4.3 North America Gestational Diabetes Market by Country

Chapter 5. North America Human Insulin Market by Product Type

5.1 North America Pens Market by Country
5.2 North America Syringes Market by Country
5.3 North America Others Market by Country

Chapter 6. North America Human Insulin Market by Type of Insulin

6.1 North America Rapid-acting insulin Market by Country
6.2 North America Short-acting insulin Market by Country
6.3 North America Intermediate-acting insulin Market by Country
6.4 North America Others Market by Country

Chapter 7. North America Human Insulin Market by Distribution Channel

7.1 North America Hospital Pharmacies Market by Country
7.2 North America Drug Stores & Retail Pharmacies Market by Country
7.3 North America Online Providers Market by Country

Chapter 8. North America Human Insulin Market by Country

8.1 US Human Insulin Market
- 8.1.1 US Human Insulin Market by Indication
- 8.1.2 US Human Insulin Market by Product Type
- 8.1.3 US Human Insulin Market by Type of Insulin
- 8.1.4 US Human Insulin Market by Distribution Channel
8.2 Canada Human Insulin Market
- 8.2.1 Canada Human Insulin Market by Indication
- 8.2.2 Canada Human Insulin Market by Product Type
- 8.2.3 Canada Human Insulin Market by Type of Insulin
- 8.2.4 Canada Human Insulin Market by Distribution Channel
8.3 Mexico Human Insulin Market
- 8.3.1 Mexico Human Insulin Market by Indication
- 8.3.2 Mexico Human Insulin Market by Product Type
- 8.3.3 Mexico Human Insulin Market by Type of Insulin
- 8.3.4 Mexico Human Insulin Market by Distribution Channel
8.4 Rest of North America Human Insulin Market
- 8.4.1 Rest of North America Human Insulin Market by Indication
- 8.4.2 Rest of North America Human Insulin Market by Product Type
- 8.4.3 Rest of North America Human Insulin Market by Type of Insulin
- 8.4.4 Rest of North America Human Insulin Market by Distribution Channel

Chapter 9. Company Profiles

9.1 Biocon Limited
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Research & Development Expenses
9.2 Tonghua Dongbao Pharmaceutical Co., Ltd.
- 9.2.1 Company Overview
9.3 Lupin Limited
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Regional Analysis
- 9.3.4 Research & Development Expenses
- 9.3.5 SWOT Analysis
9.4 MannKind Corporation
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
9.5 Sanofi S.A.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expense
- 9.5.5 SWOT Analysis
9.6 Novo Nordisk A/S
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental & Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 SWOT Analysis
9.7 Medtronic PLC
- 9.7.1 Company overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental and Regional Analysis
- 9.7.4 Research & Development Expenses
- 9.7.5 SWOT Analysis
9.8 Eli Lilly And Company
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 SWOT Analysis
9.9 Pfizer, Inc.
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional & Segmental Analysis
- 9.9.4 Research & Development Expense
- 9.9.5 SWOT Analysis

LIST OF TABLES

TABLE 1 North America Human Insulin Market, 2020 - 2023, USD Million
TABLE 2 North America Human Insulin Market, 2024 - 2031, USD Million
TABLE 3 North America Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 4 North America Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 5 North America Type 1 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 6 North America Type 1 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 7 North America Type 2 Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 8 North America Type 2 Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 9 North America Gestational Diabetes Market by Country, 2020 - 2023, USD Million
TABLE 10 North America Gestational Diabetes Market by Country, 2024 - 2031, USD Million
TABLE 11 North America Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 12 North America Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 13 North America Pens Market by Country, 2020 - 2023, USD Million
TABLE 14 North America Pens Market by Country, 2024 - 2031, USD Million
TABLE 15 North America Syringes Market by Country, 2020 - 2023, USD Million
TABLE 16 North America Syringes Market by Country, 2024 - 2031, USD Million
TABLE 17 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 18 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 19 North America Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 20 North America Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 21 North America Rapid-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 22 North America Rapid-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 23 North America Short-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 24 North America Short-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 25 North America Intermediate-acting insulin Market by Country, 2020 - 2023, USD Million
TABLE 26 North America Intermediate-acting insulin Market by Country, 2024 - 2031, USD Million
TABLE 27 North America Others Market by Country, 2020 - 2023, USD Million
TABLE 28 North America Others Market by Country, 2024 - 2031, USD Million
TABLE 29 North America Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 30 North America Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 31 North America Hospital Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 32 North America Hospital Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 33 North America Drug Stores & Retail Pharmacies Market by Country, 2020 - 2023, USD Million
TABLE 34 North America Drug Stores & Retail Pharmacies Market by Country, 2024 - 2031, USD Million
TABLE 35 North America Online Providers Market by Country, 2020 - 2023, USD Million
TABLE 36 North America Online Providers Market by Country, 2024 - 2031, USD Million
TABLE 37 North America Human Insulin Market by Country, 2020 - 2023, USD Million
TABLE 38 North America Human Insulin Market by Country, 2024 - 2031, USD Million
TABLE 39 US Human Insulin Market, 2020 - 2023, USD Million
TABLE 40 US Human Insulin Market, 2024 - 2031, USD Million
TABLE 41 US Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 42 US Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 43 US Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 44 US Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 45 US Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 46 US Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 47 US Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 48 US Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 49 Canada Human Insulin Market, 2020 - 2023, USD Million
TABLE 50 Canada Human Insulin Market, 2024 - 2031, USD Million
TABLE 51 Canada Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 52 Canada Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 53 Canada Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 54 Canada Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 55 Canada Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 56 Canada Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 57 Canada Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 58 Canada Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 59 Mexico Human Insulin Market, 2020 - 2023, USD Million
TABLE 60 Mexico Human Insulin Market, 2024 - 2031, USD Million
TABLE 61 Mexico Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 62 Mexico Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 63 Mexico Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 64 Mexico Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 65 Mexico Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 66 Mexico Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 67 Mexico Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 68 Mexico Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 69 Rest of North America Human Insulin Market, 2020 - 2023, USD Million
TABLE 70 Rest of North America Human Insulin Market, 2024 - 2031, USD Million
TABLE 71 Rest of North America Human Insulin Market by Indication, 2020 - 2023, USD Million
TABLE 72 Rest of North America Human Insulin Market by Indication, 2024 - 2031, USD Million
TABLE 73 Rest of North America Human Insulin Market by Product Type, 2020 - 2023, USD Million
TABLE 74 Rest of North America Human Insulin Market by Product Type, 2024 - 2031, USD Million
TABLE 75 Rest of North America Human Insulin Market by Type of Insulin, 2020 - 2023, USD Million
TABLE 76 Rest of North America Human Insulin Market by Type of Insulin, 2024 - 2031, USD Million
TABLE 77 Rest of North America Human Insulin Market by Distribution Channel, 2020 - 2023, USD Million
TABLE 78 Rest of North America Human Insulin Market by Distribution Channel, 2024 - 2031, USD Million
TABLE 79 Key Information - Biocon Limited
TABLE 80 Key Information - Tonghua Dongbao Pharmaceutical Co., Ltd.
TABLE 81 Key Information - Lupin Limited
TABLE 82 Key Information - MannKind Corporation
TABLE 83 Key Information - Sanofi S.A.
TABLE 84 Key Information - Novo Nordisk A/S
TABLE 85 Key Information - Medtronic PLC
TABLE 86 Key Information - Eli Lilly And Company
TABLE 87 Key Information - Pfizer, Inc.

North America Human Insulin Market Size, Share & Trends Analysis Report By Indication, By Product Type (Pens, Syringes, and Others), By Type of Insulin, By Distribution Channel, By Country and Growth Forecast, 2024 - 2031

Description

Table of Contents